NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CAO Jeffrey J. Scherman sold 1,368 shares of the company’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $10,027.44. Following the completion of the transaction, the chief accounting officer now owns 5,942 shares of the company’s stock, valued at approximately $43,554.86. This trade represents a 18.71 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
NeueHealth Stock Performance
Shares of NEUE opened at $7.45 on Thursday. NeueHealth, Inc. has a one year low of $3.79 and a one year high of $16.59. The stock’s fifty day moving average is $5.51 and its 200-day moving average is $5.39. The firm has a market capitalization of $61.72 million, a price-to-earnings ratio of -0.15 and a beta of 0.57.
Hedge Funds Weigh In On NeueHealth
Large investors have recently bought and sold shares of the stock. Renaissance Technologies LLC bought a new stake in shares of NeueHealth in the 2nd quarter worth $312,000. Partners Group Holding AG acquired a new position in NeueHealth during the third quarter worth about $463,000. Deer Management Co. LLC acquired a new position in NeueHealth during the second quarter worth about $5,436,000. Finally, NEA Management Company LLC bought a new stake in NeueHealth in the second quarter worth about $14,834,000. Institutional investors and hedge funds own 63.88% of the company’s stock.
Analyst Upgrades and Downgrades
Get Our Latest Analysis on NEUE
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Featured Articles
- Five stocks we like better than NeueHealth
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Why AMD Stock Might Already Be This Year’s Best Buy
- What Are Dividend Achievers? An Introduction
- 3 Promising Penny Stocks to Watch for Long-Term Gains in 2025
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- The 3 Kings of Buybacks in 2024: Can They Do It Again?
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.